Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 15, 2022 / 02:00PM GMT
Release Date Price: €91.7 (-5.56%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good morning, everyone. I'm Steven Lichtman, medical devices analyst at Oppenheimer, and welcome to the 32nd Annual Oppenheimer Healthcare Conference. Next up for us this morning, very happy to have with us Tandem Diabetes. With us today are President and CEO, John Sheridan; and EVP and CFO, Leigh Vosseller. We'll be doing a fireside chat format this morning. If anyone does have a question, please key it in, and I'll make sure to get it over to management. With that, I would like to turn it over to John for a couple of opening comments, and then we'll dive in. John?

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks, Steve. It's great to see you again. I just wanted to say that -- I mean this is probably known to everybody, but we had a strong finish to the year last year, a great fourth quarter and a really good year as well when you consider the unpredictability of the COVID situation that we faced. I think it's largely driven by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot